ClinicalTrials.Veeva

Menu

A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Asthma

Study type

Observational

Funder types

Industry

Identifiers

NCT00986219
NIS-RGR-DUM-2009/1

Details and patient eligibility

About

The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.

Enrollment

696 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time

Exclusion criteria

  • Patient with a cardiac disease (congestive heart failure, coronary heart disease)
  • Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)

Trial design

696 participants in 1 patient group

Asthma Language between patients and physicians

Trial contacts and locations

40

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems